Home/Filings/4/0000899243-20-013708
4//SEC Filing

Flagship Ventures Fund IV General Partner LLC 4

Accession 0000899243-20-013708

CIK 0001633070other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:15 PM ET

Size

21.0 KB

Accession

0000899243-20-013708

Insider Transaction Report

Form 4
Period: 2020-05-18
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,035,830
  • Common Stock

    (indirect: See Footnote)
    1,761,029
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,035,830
  • Common Stock

    (indirect: See Footnote)
    1,761,029
AFEYAN NOUBAR
10% Owner
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,761,029
  • Common Stock

    (indirect: See Footnote)
    2,035,830
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,035,830
  • Common Stock

    (indirect: See Footnote)
    1,761,029
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,035,830
  • Common Stock

    (indirect: See Footnote)
    1,761,029
Transactions
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,520,000$7,220,0004,808,780 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+380,000$1,805,0001,056,752 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-05-18$4.75/sh+1,900,000$9,025,0002,886,023 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,761,029
  • Common Stock

    (indirect: See Footnote)
    2,035,830
Footnotes (5)
  • [F1]Shares held by Flagship Ventures Fund IV, L.P. ("Flagship Fund IV"). Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Edwin M. Kania, Jr. is retired both from Flagship Pioneering, Inc. and as a manager of Flagship Fund IV GP.
  • [F2]Shares held by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  • [F3]Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Opportunities. Each of the reporting persons except for Flagship Opportunities I disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
  • [F4]Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  • [F5]Shares held by Flagship Ventures Fund 2007, L.P. ("Flagship Fund 2007"). Flagship Ventures 2007 General Partner LLC ("Fund 2007 GP") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. is the sole manager of Fund 2007 GP. Each of the reporting persons except for Flagship Fund 2007 disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Edwin M. Kania, Jr. is retired both from Flagship Pioneering, Inc. and as a manager of Fund 2007 GP.

Issuer

Axcella Health Inc.

CIK 0001633070

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001508051

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:15 PM ET
Size
21.0 KB